The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynairgen Share News (SNG)

Share Price Information for Synairgen (SNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.20
Bid: 5.52
Ask: 7.00
Change: 0.08 (1.31%)
Spread: 1.48 (26.812%)
Open: 6.20
High: 6.20
Low: 6.20
Prev. Close: 6.12
SNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 23rd Sep 2021 15:59

Friday 24 September 
Carnival PLCQ3 Results
Dunedin Enterprise Investment Trust PLCHalf Year Results
Judges Scientific PLCHalf Year Results
Monday 27 September 
Beeks Financial Cloud Group PLCFull Year Results
FireAngel Safety Technology GroupHalf Year Results
i3 Energy PLCHalf Year Results
Instem PLCHalf Year Results
Medica Group PLCHalf Year Results
Microsaic Systems PLCHalf Year Results
Minds + Machines Group LtdHalf Year Results
Oxford Cannabinoid Technologies Holdings PLCFull Year Results
United Utilities Group PLCTrading Statement
Tuesday 28 September 
AG Barr PLCHalf Year Results
Animalcare Group PLCHalf Year Results
Blancco Technology Group PLCFull Year Results
Brand Architekts Group PLCFull Year Results
Card Factory PLCHalf Year Results
Close Brothers Group PLCFull Year Results
Digitalbox PLCHalf Year Results
Ergomed PLCHalf Year Results
Escape Hunt PLCHalf Year Results
Ferguson PLCFull Year Results
HeiQ PLCHalf Year Results
Hotel Chocolat Group PLCFull Year Results
Immotion Group PLCHalf Year Results
Itaconix PLCHalf Year Results
Lords Group Trading PLCHalf Year Results
Moonpig Group PLCTrading Statement
Mortgage Advice Bureau Holdings PLCHalf Year Results
Next Fifteen Communications Group PLCHalf Year Results
Northcoders Group PLCHalf Year Results
Pennon Group PLCTrading Statement
S&U plcHalf Year Results
Serica Energy PLCHalf Year Results
Smiths Group PLCFull Year Results
SourceBio International PLCHalf Year Results
Transense Technologies PLCFull Year Results
Yourgene Health PLCTrading Statement
Wednesday 29 September 
1Spatial PLCHalf Year Results
Allied Minds PLCHalf Year Results
Cap-XX LtdFull Year Results
CMO Group PLCHalf Year Results
Futura Medical PLCHalf Year Results
Glantus Holdings PLCHalf Year Results
MyCelx Technologies CorpHalf Year Results
MyHealthChecked PLCHalf Year Results
NetScientific PLCHalf Year Results
Next PLCHalf Year Results
Origin Enterprises PLCFull Year Results
Quiz PLCFull Year Results
SEEEN PLCHalf Year Results
SSE PLCTrading Statement
SSP Group PLCTrading Statement
Sumo Group PLCHalf Year Results
Yu Group PLCHalf Year Results
Thursday 30 September 
Angle PLCHalf Year Results
Avacta Group PLCHalf Year Results
Boohoo Group PLCHalf Year Results
Ceres Power Holdings PLCHalf Year Results
Go-Ahead Group PLCFull Year Results
Physiomics PLCFull Year Results
Power Metal Resources PLCTrading Statement
Renishaw PLCFull Year Results
Rockhopper Exploration PLCHalf Year Results
Synairgen PLCHalf Year Results
WANdisco PLCHalf Year Results
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 Sep 2020 19:32

IN BRIEF: Synairgen Reports Promising Findings From SNG001 Trial

IN BRIEF: Synairgen Reports Promising Findings From SNG001 Trial

Read more
8 Sep 2020 15:16

Synairgen upbeat on latest data from SNG001 trials

(Sharecast News) - Respiratory drug discovery and development company Synairgen announced positive data from the interim analysis of its exploratory phase 2 clinical trial of inhaled 'SNG001' on Tuesday, in chronic obstructive pulmonary disease (COPD) patients with a confirmed respiratory viral infection.

Read more
21 Jul 2020 15:51

IN BRIEF: Synairgen Moving "Rapidly" To Get SNG001 Over Line

IN BRIEF: Synairgen Moving "Rapidly" To Get SNG001 Over Line

Read more
20 Jul 2020 20:23

COVID SCIENCE-Multiple vaccine candidates show early promise; inhaled interferon helps severe COVID-19 patients

By Nancy LapidJuly 20 (Reuters) - The following is a brief roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.Early tests of COVID-19 ...

Read more
20 Jul 2020 16:55

LONDON MARKET CLOSE: FTSE 100 Lags Despite Encouraging Vaccine News

LONDON MARKET CLOSE: FTSE 100 Lags Despite Encouraging Vaccine News

Read more
20 Jul 2020 11:54

Synairgen Shares Soar On Positive Trial Results For Covid-19 Treatment

Synairgen Shares Soar On Positive Trial Results For Covid-19 Treatment

Read more
20 Jul 2020 09:10

REFILE-UPDATE 2-Synairgen soars after drug shows promise in COVID-19 cases

(Refiles to correct spelling in the media identifier)* Shares hit all-time high on Monday* Company's drug cuts risk of severe COVID-19 by 79%* Some researchers caution on enthusiasmBy Aakash BJuly 20 (Reuters) - Synairgen shares rose almost sixfold ...

Read more
20 Jul 2020 09:10

UPDATE 2-Synairgen soars after drug shows promise in COVID-19 cases

* Shares hit all-time high on Monday* Company's drug cuts risk of severe COVID-19 by 79%* Some researchers caution on enthusiasm (Recasts, adds comment from CEO and academic expert)By Aakash BJuly 20 (Reuters) - Synairgen shares rose almost sixfold...

Read more
20 Jul 2020 09:10

UPDATE 1-Synairgen shares soar as drug shows lower risk of severe COVID-19 cases

(Adds details on the trial, shares)July 20 (Reuters) - Synairgen Plc said on Monday its drug helped reduce the risk of severe cases in hospitalised patients with COVID-19, according to data from a trial of more than 100 people in the United Kingdo...

Read more
20 Jul 2020 07:56

Europe open: Stocks reverse early losses, healthcare leads

(Sharecast News) - Stocks have recovered from early selling following news that European Union leaders meeting in Brussels had made progress on the terms for a reconstruction fund.

Read more
20 Jul 2020 07:56

Synairgen's drug shows reduced risk of severe disease in COVID-19 patients

July 20 (Reuters) - Synairgen Plc said on Monday its drug helped reduce the risk of developing severe diseases in hospitalised COVID-19 patients, according to data from a trial of more than 100 people in the United Kingdom.The trial, which used in...

Read more
20 Jul 2020 07:20

Synairgen treatment reduces risk of 'severe' Covid-19 by 79%

(Sharecast News) - Synairgen's Covid-19 treatment sharply reduced the risk of patients developing severe forms of the illness provoked by the novel coronavirus, clinical trials showed.

Read more
22 Jun 2020 16:09

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
18 Jun 2020 17:59

IN BRIEF: Synairgen Expands Home Setting Trial Of Inhaled SNG001

IN BRIEF: Synairgen Expands Home Setting Trial Of Inhaled SNG001

Read more
18 Jun 2020 09:12

Synairgen expands Covid-19 trial nationwide

(Sharecast News) - Synairgen is to expand trials of a potential treatment for Covid-19 nationally, the respiratory drug specialist said on Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.